Retractable Technologies Inc (RVP)
0.9407
+0.01
(+0.77%)
USD |
NYAM |
May 24, 16:00
0.9425
0.00 (0.00%)
After-Hours: 20:00
Retractable Technologies Research and Development Expense (TTM): 0.5937M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.5937M |
| December 31, 2023 | 0.5812M |
| September 30, 2023 | 0.5375M |
| June 30, 2023 | 0.4923M |
| March 31, 2023 | 0.5599M |
| December 31, 2022 | 0.5257M |
| September 30, 2022 | 0.5615M |
| June 30, 2022 | 0.655M |
| March 31, 2022 | 0.8476M |
| December 31, 2021 | 0.9014M |
| September 30, 2021 | 0.9227M |
| June 30, 2021 | 0.8581M |
| March 31, 2021 | 0.5853M |
| December 31, 2020 | 0.5745M |
| September 30, 2020 | 0.5376M |
| June 30, 2020 | 0.5379M |
| March 31, 2020 | 0.5272M |
| December 31, 2019 | 0.5161M |
| September 30, 2019 | 0.5671M |
| June 30, 2019 | 0.5786M |
| March 31, 2019 | 0.6046M |
| December 31, 2018 | 0.6214M |
| September 30, 2018 | 0.707M |
| June 30, 2018 | 0.7204M |
| March 31, 2018 | 0.7363M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.7406M |
| September 30, 2017 | 0.6479M |
| June 30, 2017 | 0.6059M |
| March 31, 2017 | 0.5954M |
| December 31, 2016 | 0.5718M |
| September 30, 2016 | 0.5875M |
| June 30, 2016 | 0.5953M |
| March 31, 2016 | 0.6161M |
| December 31, 2015 | 0.6075M |
| September 30, 2015 | 0.5204M |
| June 30, 2015 | 0.5238M |
| March 31, 2015 | 0.5484M |
| December 31, 2014 | 0.6168M |
| September 30, 2014 | 0.695M |
| June 30, 2014 | 0.8338M |
| March 31, 2014 | 0.8409M |
| December 31, 2013 | 0.8371M |
| September 30, 2013 | 0.9191M |
| June 30, 2013 | 0.8951M |
| March 31, 2013 | 0.8612M |
| December 31, 2012 | 0.8719M |
| September 30, 2012 | 0.8769M |
| June 30, 2012 | 0.8021M |
| March 31, 2012 | 0.8163M |
| December 31, 2011 | 0.815M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.4923M
Minimum
Jun 2023
0.9227M
Maximum
Sep 2021
0.623M
Average
0.5708M
Median
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 24.91M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 1.689M |
| Asensus Surgical Inc | 34.98M |
| Catheter Precision Inc | 0.272M |